World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
101
Citations
58821
World Ranking
7804
National Ranking
262

Luigi Bolondi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Luigi Bolondi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 623 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Luigi Bolondi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Luigi Bolondi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 101 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Luigi Bolondi is affiliated with the University of Bologna in Italy and focuses their research primarily in the field of Medicine. Their work has a particular emphasis on Hepatology, with additional contributions to Pathology and Forensic Medicine, Critical Care and Intensive Care Medicine, Pulmonary and Respiratory Medicine, and Radiology, Nuclear Medicine and Imaging.

The main topics covered in their research include:

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cancer Mechanisms and Therapy
  • Liver Physiology and Pathology
  • Ultrasound in Clinical Applications
  • Phonocardiography and Auscultation Techniques
  • Ultrasound Imaging and Elastography
  • Liver Disease and Transplantation

Luigi Bolondi has contributed to publications in several scientific venues. These include:

  • ESMO Open
  • Medical Ultrasonography
  • Journal of Nephrology
  • Hepatoma Research

Recent papers authored or co-authored by Luigi Bolondi include:

  • Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial, 2020, ESMO Open
  • History of Ultrasound in Medicine from its birth to date (2022), on occasion of the 50 Years Anniversary of EFSUMB. A publication of the European Federation of Societies for Ultrasound In Medicine and Biology (EFSUMB), designed to record the historical development of medical ultrasound, 2022, Medical Ultrasonography
  • Detoxification of bilirubin and bile acids with intermittent coupled plasmafiltration and adsorption in liver failure (HERCOLE study), 2020, Journal of Nephrology
  • BOOST: a phase 3 trial of sorafenib vs. best supportive care in first line treatment of hepatocellular carcinoma in patients with deteriorated liver function, 2021, Hepatoma Research

Some of the frequent co-authors contributing to Luigi Bolondi's research include:

  • Fabio Piscaglia
  • RobinKate Kelley
  • Baek-Yeol Ryoo
  • Philippe Merle
  • Joong-Won Park

Best Publications

  • Sorafenib in Advanced Hepatocellular Carcinoma

    Josep M. Llovet;Sergio Ricci;Vincenzo Mazzaferro;Philip Hilgard

  • Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

    Ghassan K. Abou-Alfa;Tim Meyer;Ann Lii Cheng;Anthony B. El-Khoueiry

  • Hepatocellular Carcinoma and Cirrhosis in 746 Patients: Long-Term Results of Percutaneous Ethanol Injection

    T Livraghi;A Giorgio;G Marin;A Salmi

  • Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - Update 2008

    M. Claudon;D. Cosgrove;T. Albrecht;L. Bolondi

  • Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma

    Laura Gramantieri;Manuela Ferracin;Francesca Fornari;Angelo Veronese

  • Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial

    Jordi Bruix;Tadatoshi Takayama;Vincenzo Mazzaferro;Gar Yang Chau

  • Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

    Fabio Conti;Federica Buonfiglioli;Alessandra Scuteri;Cristina Crespi

  • Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.

    Jordi Bruix;Jean Luc Raoul;Morris Sherman;Vincenzo Mazzaferro

  • Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis

    L Bolondi;S Sofia;S Siringo;S Gaiani

  • MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.

    Francesca Fornari;Laura Gramantieri;Manuela Ferracin;A Veronese

  • Guidelines for the Use of Contrast Agents in Ultrasound - January 2004

    T Albrecht;M Blomley;L Bolondi;M Claudon

  • Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions.

    Luigi Bolondi;Andrew Burroughs;Jean François Dufour;Peterr R. Galle

  • The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations.

    Fabio Piscaglia;Luigi Bolondi

  • Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization

    J.-L. Raoul;B. Sangro;A. Forner;V. Mazzaferro

  • Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma

    R Golfieri;E Giampalma;M Renzulli;R Cioni

  • Percutaneous Ethanol Injection in the Treatment of Hepatocellular Carcinoma in Cirrhosis. A Study on 207 Patients

    Tito Livraghi;Luigi Bolondi;Sergio Lazzaroni;Giuseppe Marin

  • Measurement of Gastric Emptying Time by Real-Time Ultrasonography

    Luigi Bolondi;Mauro Bortolotti;Vittorio Santi;Tiziana Calletti

  • Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival.

    Luigi Barbara;Giovanna Benzi;Stefano Gaiani;Fabio Fusconi

  • Characterization of small nodules in cirrhosis by assessment of vascularity: The problem of hypovascular hepatocellular carcinoma

    Luigi Bolondi;Stefano Gaiani;Natascia Celli;Rita Golfieri

  • MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.

    Francesca Fornari;Laura Gramantieri;Catia Giovannini;Angelo Veronese

Frequent Co-Authors

Fabio Piscaglia
Fabio Piscaglia University of Bologna
Luigi Barbara
Luigi Barbara University of Bologna
Massimo Negrini
Massimo Negrini University of Ferrara
Antonio Daniele Pinna
Antonio Daniele Pinna University of Bologna
Gian Luca Grazi
Gian Luca Grazi University of Bologna
Marco Valgimigli
Marco Valgimigli University of Bern
Carlo M. Croce
Carlo M. Croce The Ohio State University
Mauro Bernardi
Mauro Bernardi University of Bologna
Massimo Colombo
Massimo Colombo Humanitas University
Marco Zoli
Marco Zoli University of Bologna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While earning a medical degree traditionally requires in-person study and clinical work, there are many online degree options in related healthcare fields that support flexible learning and career advancement. For those interested in patient wellness and preventative care, online degrees in nutrition can lead to meaningful roles in hospitals, clinics, or community health.

Advancing into healthcare management is also possible through cahme-accredited online mha programs, which prepare graduates for administrative and leadership positions in medical organizations. Current nurses can further their education and job prospects by enrolling in online rn to bsn programs no clinicals, designed for working professionals seeking to build upon their RN credentials without additional in-person clinical requirements.

For those aiming for the highest levels of nursing practice, short dnp programs online offer accelerated pathways to a Doctor of Nursing Practice degree—often with flexible schedules for busy professionals. Exploring these online options can help you tailor your education to match your career goals in the evolving healthcare landscape.

Best Scientists Citing Luigi Bolondi

Trending Scientists

Recently Published Articles